chr11-18243537-G-C

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The ENST00000524555.3(SAA2-SAA4):​c.230+2373C>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.92 in 152,240 control chromosomes in the GnomAD database, including 64,522 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.92 ( 64522 hom., cov: 31)

Consequence

SAA2-SAA4
ENST00000524555.3 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.149

Publications

1 publications found
Variant links:
Genes affected
SAA2-SAA4 (HGNC:39550): (SAA2-SAA4 readthrough) This locus represents naturally occurring read-through transcription between the neighboring serum amyloid A2 and serum amyloid A4 genes on chromosome 11. The read-through transcript produces a fusion protein that shares sequence identity with each individual gene product. [provided by RefSeq, Dec 2010]
SAA2 (HGNC:10514): (serum amyloid A2) This gene encodes a member of the serum amyloid A family of apolipoproteins. The encoded preproprotein is proteolytically processed to generate the mature protein. This protein is a major acute phase protein that is highly expressed in response to inflammation and tissue injury. This protein also plays an important role in HDL metabolism and cholesterol homeostasis. High levels of this protein are associated with chronic inflammatory diseases including atherosclerosis, rheumatoid arthritis, Alzheimer's disease and Crohn's disease. This protein may also be a potential biomarker for certain tumors. Finally, antimicrobial activity against S. aureus and E. coli resides in the N-terminal portion of the mature protein. [provided by RefSeq, Jul 2020]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.89).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.938 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SAA2-SAA4NM_001199744.2 linkc.230+2373C>G intron_variant Intron 3 of 5 NP_001186673.1 A0A096LPE2
SAA2NM_001127380.3 linkc.230+2373C>G intron_variant Intron 3 of 3 NP_001120852.1 P0DJI9-2
SAA2NM_001385667.1 linkc.230+2373C>G intron_variant Intron 4 of 4 NP_001372596.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SAA2-SAA4ENST00000524555.3 linkc.230+2373C>G intron_variant Intron 3 of 5 3 ENSP00000485552.1 A0A096LPE2
SAA2ENST00000414546.6 linkc.230+2373C>G intron_variant Intron 3 of 3 1 ENSP00000416716.2 P0DJI9-2
SAA2ENST00000528349.5 linkc.231-718C>G intron_variant Intron 3 of 3 2 ENSP00000435659.1 G3V1D9
SAA2ENST00000530400.5 linkc.230+2373C>G intron_variant Intron 2 of 2 3 ENSP00000432370.1 E9PR14

Frequencies

GnomAD3 genomes
AF:
0.920
AC:
139920
AN:
152122
Hom.:
64477
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.875
Gnomad AMI
AF:
0.917
Gnomad AMR
AF:
0.886
Gnomad ASJ
AF:
0.954
Gnomad EAS
AF:
0.932
Gnomad SAS
AF:
0.903
Gnomad FIN
AF:
0.976
Gnomad MID
AF:
0.930
Gnomad NFE
AF:
0.944
Gnomad OTH
AF:
0.925
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.920
AC:
140022
AN:
152240
Hom.:
64522
Cov.:
31
AF XY:
0.921
AC XY:
68536
AN XY:
74430
show subpopulations
African (AFR)
AF:
0.875
AC:
36325
AN:
41524
American (AMR)
AF:
0.886
AC:
13547
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
0.954
AC:
3310
AN:
3470
East Asian (EAS)
AF:
0.932
AC:
4829
AN:
5180
South Asian (SAS)
AF:
0.904
AC:
4365
AN:
4826
European-Finnish (FIN)
AF:
0.976
AC:
10369
AN:
10620
Middle Eastern (MID)
AF:
0.925
AC:
272
AN:
294
European-Non Finnish (NFE)
AF:
0.944
AC:
64216
AN:
68010
Other (OTH)
AF:
0.923
AC:
1953
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
559
1118
1676
2235
2794
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
908
1816
2724
3632
4540
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.934
Hom.:
2202
Bravo
AF:
0.910

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.89
CADD
Benign
3.6
DANN
Benign
0.47
PhyloP100
-0.15
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2460824; hg19: chr11-18265084; API